Howard Colman

The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors

J. Matthew McDonald, Siew Ju See, Ivo Tremont et al. · Cancer · 2005 · 106 citations

An orally administered opiate blocker, naltrexone, attenuates self-injurious behavior.

C.A. Sandman, Jennifer L. Barron, Howard Colman · PubMed · 1990 · 94 citations

Opioid Epidemic, Pharmacotherapy, Drug Treatment +17

RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).

Mark R. Gilbert, James J. Dignam, Minhee Won et al. · Journal of Clinical Oncology · 2013 · 65 citations

Mgmt Methylation, High-grade Gliomas, Glioma +21

Molecular predictors of outcome and response to bevacizumab (BEV) based on analysis of RTOG 0825, a phase III trial comparing chemoradiation (CRT) with and without BEV in patients with newly diagnosed glioblastoma (GBM).

Erik P. Sulman, Minhee Won, Deborah T. Blumenthal et al. · Journal of Clinical Oncology · 2013 · 22 citations

Genetic Epidemiology, Pathology, High-grade Gliomas +21

ACTR-39. PAMIPARIB IN COMBINATION WITH RADIATION THERAPY (RT) AND/OR TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED OR RECURRENT/REFRACTORY (R/R) GLIOBLASTOMA (GBM); PHASE 1B/2 STUDY UPDATE

Anna F. Piotrowski, Vinay K. Puduvalli, Patrick Y. Wen et al. · Neuro-Oncology · 2019 · 16 citations · Full text

Immunology, Pamiparib 60, Pharmacotherapy +25